- Home
- TIL vs PSNL Comparison
TIL vs PSNL Comparison
Compare TIL & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- PSNL
- Stock Information
- Founded
- TIL 2018
- PSNL 2011
- Country
- TIL United States
- PSNL United States
- Employees
- TIL N/A
- PSNL N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- PSNL Medical Specialities
- Sector
- TIL Health Care
- PSNL Health Care
- Exchange
- TIL Nasdaq
- PSNL Nasdaq
- Market Cap
- TIL 230.1M
- PSNL 576.8M
- IPO Year
- TIL 2021
- PSNL 2019
- Fundamental
- Price
- TIL $28.30
- PSNL $7.32
- Analyst Decision
- TIL Buy
- PSNL Strong Buy
- Analyst Count
- TIL 5
- PSNL 5
- Target Price
- TIL $119.00
- PSNL $8.00
- AVG Volume (30 Days)
- TIL 349.6K
- PSNL 1.7M
- Earning Date
- TIL 08-12-2025
- PSNL 08-06-2025
- Dividend Yield
- TIL N/A
- PSNL N/A
- EPS Growth
- TIL N/A
- PSNL N/A
- EPS
- TIL N/A
- PSNL N/A
- Revenue
- TIL N/A
- PSNL $85,694,000.00
- Revenue This Year
- TIL N/A
- PSNL $0.45
- Revenue Next Year
- TIL N/A
- PSNL $25.75
- P/E Ratio
- TIL N/A
- PSNL N/A
- Revenue Growth
- TIL N/A
- PSNL 15.57
- 52 Week Low
- TIL $9.62
- PSNL $1.19
- 52 Week High
- TIL $92.00
- PSNL $7.73
- Technical
- Relative Strength Index (RSI)
- TIL 46.80
- PSNL 79.86
- Support Level
- TIL $20.60
- PSNL $6.27
- Resistance Level
- TIL $25.95
- PSNL $7.03
- Average True Range (ATR)
- TIL 3.47
- PSNL 0.49
- MACD
- TIL -1.29
- PSNL 0.10
- Stochastic Oscillator
- TIL 22.74
- PSNL 94.69
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.